Atlas Trials

Transarterial Chemoembolization With Doxorubicin With or Without Everolimus in Treating Patients With Liver Cancer

Clinical trial NCT01009801 · TERMINATED

Trial details

NCT number
NCT01009801
Sponsor
Swiss Cancer Institute
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Liver Cancer
Start date
2010-02-01
Primary completion
2011-11-01
Enrollment
27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.